Testing mailed self-sampling kits for cervical cancer screening in women
Tests mailed HPV self-sampling kits for cervical cancer screening in women aged 30 to 65.
Plain-language title generated from the registry record
Registry title: HPV Self-sampling in the General Population
Key facts
- Where
- Reims and Troyes, FranceSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 65 years old?
Source: NCT06749847, who can take part
Where in France
- Regional Cancer Screening Coordinating Centre, Marne siteReims, FranceTaking people
- Regional Cancer Screening Coordinating Centre, Aube siteTroyes, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- International Agency for Research on Cancer
- Trial code
- NCT06749847
- Record updated
- 23 July 2025
- Original description
A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.Read full original descriptionShow less
HPV Self-sampling in the General Population: Efficacy, Feasibility, Acceptability and Cost-effectiveness
A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.
Inclusion: Women aged 30 to 65 years old; Living in the study area (Departments of Marne and Aube, France); At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter).
Exclusion: History of cervical cancer; Outside the target age (less than 30 years old, or 66 years old and more); Already participating in the current screening round; Total hysterectomy; Current follow-up for abnormal cervical screening result or cervical lesions.